Loading…

Beta 2-Microglobulin and the Severity of Coronary Stenosis in Patients With Acute Coronary Syndrome

Previous studies have shown that beta 2-microglobulin (B2M) could predict all-cause mortality and cardiovascular mortality in various groups of people. However, the relationship between B2M and severity of coronary stenosis in patients with acute coronary syndrome has not been established. We enroll...

Full description

Saved in:
Bibliographic Details
Published in:Heart, lung & circulation lung & circulation, 2019-04, Vol.28 (4), p.575-582
Main Authors: Zhang, Chenglong, Li, Fengjuan, Long, Tianyi, Li, Fei, Peng, Liming, Xia, Ke, Jing, Ran, Xie, Qiying, Yang, Tianlun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous studies have shown that beta 2-microglobulin (B2M) could predict all-cause mortality and cardiovascular mortality in various groups of people. However, the relationship between B2M and severity of coronary stenosis in patients with acute coronary syndrome has not been established. We enrolled 872 consecutive patients admitted with acute coronary syndrome in our study. All participants underwent coronary angiography examination or stent implantation after admission. The severity of coronary stenosis was assessed by Gensini score and the presentation of triple-vessel disease. B2M and other biochemical parameters were measured. All subjects were divided into quartiles of B2M. Multivariate linear regression and logistic regression were applied in the analysis. Gensini score and the prevalence of triple-vessel disease were elevated in accordance with increasing B2M quartiles (p=0.002 and p0.05 for both). Our data indicated that B2M was an independent risk factor of coronary stenosis in patients with acute coronary syndrome.
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2018.02.016